We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WBX:NYSEWallbox N.V. Analysis

Data as of 2026-09-15 - not real-time

$3.12

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Wallbox N.V. trades at $3.12, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Across the trailing 30 sessions it lost 3.4%. With RSI at 47.3 the momentum picture is neutral, alongside a bullish MACD signal. Recent trading has carved out support near $2.87 and resistance around $3.65.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 28.2% above the current price. Revenue is contracting at 37.5% on a -93.8% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 70.6%, a beta of 1.47 and a maximum drawdown of 67.5%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.

Top Market Events

Wallbox N.V. NYSE:WBX , a leading provider of electric vehicle "EV" charging and energy management solutions worldwide,...Wallbox N.V. WBX said on Monday that the New York Stock Exchange has accepted the company’s previously submitted plan...Yahoo Finance1monWallbox N.V. WBX Q2 FY2026 earnings call transcriptWallbox reported Q2 2026 revenue of EUR 23.9...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 3.15
  • MACD momentum is positive
  • 30-day volatility of 70.6%

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 3.15
  • Analyst targets imply +28.2% versus the current price
  • 30-day volatility of 70.6%

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Negative profit margin of -93.8%
  • Analyst targets imply +28.2% versus the current price
  • Revenue contracting at -37.5%

Key Metrics & Analysis

Financial Health

Revenue Growth-37.50%
Profit Margin-93.83%
P/E Ratio-1.2
P/B Ratio-1.5
Industry P/E27.6

Technical Analysis

TrendNeutral
RSI47.3
Support$2.87
Resistance$3.65
MA 20$3.06
MA 50$3.65
MA 200$3.15
MACDBullish
VolumeIncreasing
Fear & Greed Index89.52

Valuation

Target Price$4.00
Upside/Downside28.16%
GradeFair
TypeBlend

Risk Assessment

Beta1.47
Volatility70.57%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.